|
|
Communicating Clinical Trial Results to Physicians
This 20-page document includes best practices and supporting graphics for communicating clinical trial results to key opinion leaders and future prescribing physicians. Physicians represent the largest and most influential audience for clinical trial results. Therefore, companies concentrate the majority of their resources and efforts on effectively reaching this group. The document reviews the relative importance of communications channels and outlines tactics to initiate a cascade of influence with a hierarchy of Key Opinion Leaders and how to measure the memorability of key clinical trial messages among physicians, among several other practices. This research originated from Best Practices, LLC's consulting services.
Industries Profiled:
Pharmaceutical
Companies Profiled:
Abbott Laboratories; AstraZeneca; Aventis; Bristol-Myers Squibb; Eli Lilly; GlaxoSmithKline ; Janssen; Merck; Pharmacia; Novartis; Schering-Plough; Wyeth |
|
|